BB Biotech AG (XSWX:BION) Accounts Payable & Accrued Expense : CHF7.62 Mil (As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

What is BB Biotech AG Accounts Payable & Accrued Expense?

BB Biotech AG's quarterly accounts payable & accrued expense declined from Jun. 2023 (CHF4.55 Mil) to Sep. 2023 (CHF1.57 Mil) but then increased from Sep. 2023 (CHF1.57 Mil) to Dec. 2023 (CHF7.62 Mil).

BB Biotech AG's annual accounts payable & accrued expense declined from Dec. 2021 (CHF4.12 Mil) to Dec. 2022 (CHF3.09 Mil) but then increased from Dec. 2022 (CHF3.09 Mil) to Dec. 2023 (CHF7.62 Mil).

BB Biotech AG Accounts Payable & Accrued Expense Historical Data

The historical data trend for BB Biotech AG's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BB Biotech AG Accounts Payable & Accrued Expense Chart

BB Biotech AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

10.15

10.59

4.12

3.09

7.62

BB Biotech AG Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Dec17	Dec18	Dec19	Dec20	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															3.09	0.09	4.55	1.57	7.62

BB Biotech AG Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

BB Biotech AG (XSWX:BION) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BB Biotech AG (XSWX:BION) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

BIONz:UK BBZA:Germany

Address

Schwertstrasse 6, Schaffhausen, CHE, CH-8200

Website

https://www.bbbiotech.com

BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market and is one of the largest investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. BB Biotech follows a strategy of carefully screening and selecting biotechnology firms with a long-term time horizon and having established products in the marketplace. Geographically it earns key revenue from the Netherlands.

Executives

Prof. Dr. Mads Krogsgaard Thomsen

Supervisory Board

BB Biotech AG (XSWX:BION) Headlines

No Headlines